These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30337839)

  • 1. New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma.
    Chen B; Wang C; Zhang J; Zhou Y; Hu W; Guo T
    Cancer Cell Int; 2018; 18():157. PubMed ID: 30337839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Candidate lncRNA and Pseudogene Biomarkers Associated with Carbon-Nanotube-Induced Malignant Transformation of Lung Cells and Prediction of Potential Preventive Drugs.
    Chang G; Xie D; Hu J; Wu T; Cao K; Luo X
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer.
    Wang A; Bao Y; Wu Z; Zhao T; Wang D; Shi J; Liu B; Sun S; Yang F; Wang L; Qu L
    Cell Death Dis; 2019 Feb; 10(3):154. PubMed ID: 30770799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma.
    Xu X; Xu Y; Shi C; Wang B; Yu X; Zou Y; Hu T
    Oncotarget; 2017 Oct; 8(50):87773-87781. PubMed ID: 29152119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs as prognostic markers in human breast cancer.
    Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
    Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls.
    Wu Y; Wang YQ; Weng WW; Zhang QY; Yang XQ; Gan HL; Yang YS; Zhang PP; Sun MH; Xu MD; Wang CF
    Oncogenesis; 2016 Feb; 5(2):e192. PubMed ID: 26878386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
    Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
    Front Genet; 2022; 13():760514. PubMed ID: 35273635
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
    Gao X; Zhang S; Chen Y; Wen X; Chen M; Wang S; Zhang Y
    J Cell Biochem; 2019 Dec; 120(12):19796-19809. PubMed ID: 31338862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma.
    He HT; Xu M; Kuang Y; Han XY; Wang MQ; Yang Q
    Onco Targets Ther; 2016; 9():6399-6406. PubMed ID: 27799788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
    Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
    Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.